Harvard Bioscience (HBIO) Capital Expenditures Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 124.93 Bn | 119.72 Bn | 1.96 Bn | -29.93% |
| 2 | Becton Dickinson | 44.32 Bn | 43.51 Bn | 2.15 Bn | -11.61% |
| 3 | Alcon | 33.04 Bn | 31.39 Bn | 1.53 Bn | -10.15% |
| 4 | Medline | 32.73 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 28.99 Bn | 27.33 Bn | 890.98 Mn | 5.31% |
| 6 | West Pharmaceutical Services | 23.61 Bn | 23.18 Bn | 329.20 Mn | -16.94% |
| 7 | Solventum | 13.91 Bn | 13.35 Bn | 1.10 Bn | 8.92% |
| 8 | Cooper Companies | 13.85 Bn | 13.71 Bn | 735.40 Mn | 5.49% |
| 9 | Align Technology | 12.25 Bn | 11.19 Bn | 736.59 Mn | -21.70% |
| 10 | Harvard Bioscience | 26.88 Mn | 19.78 Mn | 12.24 Mn | 23.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.90% |
| Dec 31, 2025 | 24.09% |
| Sep 30, 2025 | -22.34% |
| Jun 30, 2025 | -41.39% |
| Mar 31, 2025 | 2.89% |
| Dec 31, 2024 | -5.62% |
| Sep 30, 2024 | 22.39% |
| Jun 30, 2024 | 58.35% |
| Mar 31, 2024 | 62.25% |
| Dec 31, 2023 | 134.94% |
| Sep 30, 2023 | -27.27% |
| Jun 30, 2023 | 22.25% |
| Mar 31, 2023 | -2.41% |
| Dec 31, 2022 | -18.74% |
| Sep 30, 2022 | 7.58% |
| Jun 30, 2022 | 16.44% |
| Mar 31, 2022 | 48.79% |
| Dec 31, 2021 | 55.62% |
| Sep 30, 2021 | 23.15% |
| Jun 30, 2021 | 13.47% |